For the treatment of the following infections caused by susceptible microorganisms: Upper respiratory tract infections including streptococcal pharyngitis and tonsillitis, acute maxillary sinusitis, and acute otitis media.
Lower respiratory tract infections including bronchitis and pneumonia.
Uncomplicated skin and skin structure infections including impetigo, folliculitis, cellulitis, abscesses (usually require surgical drainage).
Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium kansasii, Mycobacterium chelonae and Mycobacterium fortuitum (usually in combination with other antimicrobial agents).
Helicobacter pylori infections (in combination with other drugs).
Odontogenic infections.
Prevention of disseminated Mycobacterium avium complex (MAC) infection in patients with advanced HIV infection.